Medical Devices

A new partnership between US and German firms aims to untangle the complex web of global medtech development, promising a faster path from lab to bedside.

Clinical-stage Nyra Medical begins a key U.S. study for its novel mitral valve device, a strategic move challenging established players in a crowded field.

With the hire of a top tech veteran from Docusign and Google, digital lab Dandy is poised to accelerate its mission of creating a unified, AI-driven operating system for dental care.

New long-term data shows a 60-day nerve stimulation treatment helps 8 in 10 patients avoid surgery, challenging the entire strategy for chronic pain.

Presage Technologies' new FDA-cleared app turns any phone into a vital signs monitor, offering it free to hospitals to democratize healthcare access.

For millions with the debilitating condition dysautonomia, diagnosis is a long, frustrating journey. A new technology promises to replace subjective guesswork with hard data.

Canon's new AI for CT scanners promises near-photon-counting quality. Is this a true leap forward for diagnostics or a clever stopgap in a competitive market?

CurifyLabs just raised $14M to put 3D printers in pharmacies. It’s more than a tech play; it’s a calculated bet on a new era of personalized medicine.

With its first FDA clearance, Movmedix introduces a synthetic ligament used in 250,000+ global procedures. But can it win over a U.S. market wary of its history?

Vivos Inc. wins FDA approval for a human trial of RadioGel®, a targeted therapy that could offer new hope for patients with non-resectable thyroid cancer.

IceCure's ProSense™ is reshaping oncology in Brazil. A US FDA approval provided a critical tailwind, validating a less invasive future for cancer care.

A US med-tech firm just invested in a German airline. The goal: to build a private air network for organs and revolutionize a broken transplant system.

As Merit Medical preps its Q2 report, investors are watching more than numbers. Key acquisitions and product launches signal a deeper strategic shift.

Cerezen, a non-invasive device shown to reverse cognitive decline, has EU approval but remains in FDA limbo, raising questions about US patient access.

Amidst FDA warning letters and costly recalls, Integra LifeSciences appoints Topaz Kirlew as its new regulatory chief. It's a critical test of leadership.

New guidelines for ankle arthritis, a condition hitting younger workers hard, expose major gaps in medical research and a market ripe for innovation.

Xeltis's bioabsorbable aXess graft hits a major US trial milestone, signaling a strategic shift in renal care away from failing synthetics to living tissue.

A milestone in digital dentistry is more than a number. It's a forensic look at a new industrial architecture for healthcare and its impact on every patient.

Inogen creates a new COO role, tapping med-tech leader Andy Reding to drive efficiency and growth amid diversification and a challenging market.

West's $112.5M sale of its 3.5mL device to AbbVie isn't a retreat. It's a strategic pivot to dominate the high-growth, large-volume drug delivery market.